Automated hippocampal sparing whole brain radiotherapy with simultaneous integrated boost for multiple brain metastases: Halcyon, HyperArc on TrueBeam, and coplanar TrueBeam

Purpose: To demonstrate the ease and feasibility that hippocampal sparing whole brain (WB) simultaneous integrated boost (HSWB-SIB) plans can be generated using knowledge-based planning and Eclipse Scripting Application Programming Interface (ESAPI) for three different modalities, HyperArc on TrueBeam (TB-HA), a coplanar beam arrangement on TrueBeam (TB-Co), and the ring-mounted Halcyon LINAC (Hal). Methods: Twelve patients with 2–14 brain metastases were retrospectively replanned for HSWB-SIB using a published HSWB RapidPlan model with modifications for the automated addition of SIB to metastases. Prescribed dose was 30 Gy to the WB planning target volume (PTV) and 50 Gy to the metastases in 10 fractions. Eclipse treatment planning system (v16.1) was used with a 6 MV-FFF beam and Acuros XB dose algorithm. Results: The methodology was successfully used for all modalities, generating plans in under 30 min. The plan doses were normalized to the WB PTV D_95% receiving 30 Gy. Reporting values in the order of Hal, TB-Co, and TB-HA: The WB PTV received a V_48 Gy of 4.58, 3.98, and 4.45 cc with statistically insignificant differences (p = 0.806). The boost PTVs received a D_95% of 50.60, 50.43, and 51.13 Gy with statistically significant comparisons between TB-HA and the other two modalities (p = 0.005). The hippocampus maximum dose was 11.81, 11.51, and 11.13 Gy with no statistically significant comparisons (p = 0.105). All other oragns-at-risk (OAR) doses were clinically acceptable. The modalities were evaluated using a dosimetric scorecard, achieving average scores of 84.85%, 86.45%, and 87.39%. End-to-end testing ensured the deliverability of the HSWB-SIB plans for all modalities. Conclusion: The novel modification of the preexisting HSWB RapidPlan model with the automated inclusion of SIB objectives allows for easy, intuitive planning of complex HSWB-SIB treatments. All modalities demonstrated can be used with clinically comparable results. Other institutions are recommended to pursue and validate this HSWB-SIB technique to increase the accessibility of a single-course of high-quality treatment for patients with multiple brain lesions.